OMERS ADMINISTRATION Corp bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 547,569 shares of the company’s stock, valued at approximately $70,363,000. OMERS ADMINISTRATION Corp owned 0.42% of Merck KGaA as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Frazier Financial Advisors LLC acquired a new position in Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $27,000. Solstein Capital LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $33,000. Burk Holdings LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $39,000. Finally, Bard Associates Inc. purchased a new position in shares of Merck KGaA during the second quarter worth approximately $60,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Shares of Merck KGaA stock opened at $163.21 on Monday. The firm’s fifty day simple moving average is $162.62 and its 200-day simple moving average is $148.44. The stock has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
